APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anorexiant Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Anorexiant Drug Industry Research Report 2026

27 December 2025123 pages

Choose your research edition.

Industry ResearchOral Anorexiant Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anorexiant Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Oral Anorexiant Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anorexiant Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anorexiant Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Oral Anorexiant Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Anorexiant Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Anorexiant Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Anorexiant Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Anorexiant Drug include Janssen Ortho, Teva Pharmaceuticals, Roche Pharmaceuticals, Recordati Rare Diseases, Patheon Pharmaceuticals, Novo Nordisk, MOVA Pharmaceuticals, Epic Pharma and Catalent Pharma Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Anorexiant Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Anorexiant Drug Market by Company

Janssen Ortho

Teva Pharmaceuticals

Roche Pharmaceuticals

Recordati Rare Diseases

Patheon Pharmaceuticals

Novo Nordisk

MOVA Pharmaceuticals

Epic Pharma

Catalent Pharma Solutions

Arena Pharmaceuticals

Akrimax Pharmaceuticals

Abbott Pharmaceuticals

Oral Anorexiant Drug Segment by Type

Catecholamines

Serotonin

Oral Anorexiant Drug Segment by Application

Clinics

Hospitals

Online Pharmacies

Retail Sales

Other

Oral Anorexiant Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anorexiant Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anorexiant Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anorexiant Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Anorexiant Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Anorexiant Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Anorexiant Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Anorexiant Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Anorexiant Drug Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oral Anorexiant Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Anorexiant Drug Revenue of Manufacturers (2021-2026) Table 9. Global Oral Anorexiant Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Anorexiant Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oral Anorexiant Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Anorexiant Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Anorexiant Drug, Product Type & Application Table 14. Global Oral Anorexiant Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Anorexiant Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Janssen Ortho Company Information Table 19. Janssen Ortho Business Overview Table 20. Janssen Ortho Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Janssen Ortho Oral Anorexiant Drug Product Portfolio Table 22. Janssen Ortho Recent Developments Table 23. Teva Pharmaceuticals Company Information Table 24. Teva Pharmaceuticals Business Overview Table 25. Teva Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Teva Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 27. Teva Pharmaceuticals Recent Developments Table 28. Roche Pharmaceuticals Company Information Table 29. Roche Pharmaceuticals Business Overview Table 30. Roche Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Roche Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 32. Roche Pharmaceuticals Recent Developments Table 33. Recordati Rare Diseases Company Information Table 34. Recordati Rare Diseases Business Overview Table 35. Recordati Rare Diseases Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Recordati Rare Diseases Oral Anorexiant Drug Product Portfolio Table 37. Recordati Rare Diseases Recent Developments Table 38. Patheon Pharmaceuticals Company Information Table 39. Patheon Pharmaceuticals Business Overview Table 40. Patheon Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Patheon Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 42. Patheon Pharmaceuticals Recent Developments Table 43. Novo Nordisk Company Information Table 44. Novo Nordisk Business Overview Table 45. Novo Nordisk Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novo Nordisk Oral Anorexiant Drug Product Portfolio Table 47. Novo Nordisk Recent Developments Table 48. MOVA Pharmaceuticals Company Information Table 49. MOVA Pharmaceuticals Business Overview Table 50. MOVA Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. MOVA Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 52. MOVA Pharmaceuticals Recent Developments Table 53. Epic Pharma Company Information Table 54. Epic Pharma Business Overview Table 55. Epic Pharma Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Epic Pharma Oral Anorexiant Drug Product Portfolio Table 57. Epic Pharma Recent Developments Table 58. Catalent Pharma Solutions Company Information Table 59. Catalent Pharma Solutions Business Overview Table 60. Catalent Pharma Solutions Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Catalent Pharma Solutions Oral Anorexiant Drug Product Portfolio Table 62. Catalent Pharma Solutions Recent Developments Table 63. Arena Pharmaceuticals Company Information Table 64. Arena Pharmaceuticals Business Overview Table 65. Arena Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Arena Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 67. Arena Pharmaceuticals Recent Developments Table 68. Akrimax Pharmaceuticals Company Information Table 69. Akrimax Pharmaceuticals Business Overview Table 70. Akrimax Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Akrimax Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 72. Akrimax Pharmaceuticals Recent Developments Table 73. Abbott Pharmaceuticals Company Information Table 74. Abbott Pharmaceuticals Business Overview Table 75. Abbott Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Abbott Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 77. Abbott Pharmaceuticals Recent Developments Table 78. Global Oral Anorexiant Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Oral Anorexiant Drug Sales by Region (2021-2026) & (K Units) Table 80. Global Oral Anorexiant Drug Sales Market Share by Region (2021-2026) Table 81. Global Oral Anorexiant Drug Sales by Region (2027-2032) & (K Units) Table 82. Global Oral Anorexiant Drug Sales Market Share by Region (2027-2032) Table 83. Global Oral Anorexiant Drug Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Oral Anorexiant Drug Revenue Market Share by Region (2021-2026) Table 85. Global Oral Anorexiant Drug Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Oral Anorexiant Drug Revenue Market Share by Region (2027-2032) Table 87. North America Oral Anorexiant Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 89. North America Oral Anorexiant Drug Sales by Country (2027-2032) & (K Units) Table 90. North America Oral Anorexiant Drug Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Oral Anorexiant Drug Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Oral Anorexiant Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 94. Europe Oral Anorexiant Drug Sales by Country (2027-2032) & (K Units) Table 95. Europe Oral Anorexiant Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Oral Anorexiant Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Oral Anorexiant Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Oral Anorexiant Drug Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Oral Anorexiant Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Oral Anorexiant Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Oral Anorexiant Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 104. South America Oral Anorexiant Drug Sales by Country (2027-2032) & (K Units) Table 105. South America Oral Anorexiant Drug Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Oral Anorexiant Drug Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Oral Anorexiant Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Oral Anorexiant Drug Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Oral Anorexiant Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Oral Anorexiant Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 113. Global Oral Anorexiant Drug Sales by Type (2027-2032) & (K Units) Table 114. Global Oral Anorexiant Drug Sales Market Share by Type (2021-2026) Table 115. Global Oral Anorexiant Drug Sales Market Share by Type (2027-2032) Table 116. Global Oral Anorexiant Drug Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Oral Anorexiant Drug Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Oral Anorexiant Drug Revenue Market Share by Type (2021-2026) Table 119. Global Oral Anorexiant Drug Revenue Market Share by Type (2027-2032) Table 120. Global Oral Anorexiant Drug Price by Type (2021-2026) & (US$/Unit) Table 121. Global Oral Anorexiant Drug Price by Type (2027-2032) & (US$/Unit) Table 122. Global Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 123. Global Oral Anorexiant Drug Sales by Application (2027-2032) & (K Units) Table 124. Global Oral Anorexiant Drug Sales Market Share by Application (2021-2026) Table 125. Global Oral Anorexiant Drug Sales Market Share by Application (2027-2032) Table 126. Global Oral Anorexiant Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Oral Anorexiant Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Oral Anorexiant Drug Revenue Market Share by Application (2021-2026) Table 129. Global Oral Anorexiant Drug Revenue Market Share by Application (2027-2032) Table 130. Global Oral Anorexiant Drug Price by Application (2021-2026) & (US$/Unit) Table 131. Global Oral Anorexiant Drug Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Oral Anorexiant Drug Distributors List Table 135. Oral Anorexiant Drug Customers List Table 136. Oral Anorexiant Drug Industry Trends Table 137. Oral Anorexiant Drug Industry Drivers Table 138. Oral Anorexiant Drug Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Anorexiant Drug Product Image Figure 5. Global Oral Anorexiant Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Anorexiant Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Anorexiant Drug Sales (2021-2032) & (K Units) Figure 8. Global Oral Anorexiant Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Catecholamines Product Image Figure 10. Serotonin Product Image Figure 11. Clinics Product Image Figure 12. Hospitals Product Image Figure 13. Online Pharmacies Product Image Figure 14. Retail Sales Product Image Figure 15. Other Product Image Figure 16. Global Oral Anorexiant Drug Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Oral Anorexiant Drug, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Oral Anorexiant Drug Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Oral Anorexiant Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Oral Anorexiant Drug Sales by Region in 2025 Figure 22. Global Oral Anorexiant Drug Revenue by Region in 2025 Figure 23. North America Oral Anorexiant Drug Market Size by Country in 2025 Figure 24. North America Oral Anorexiant Drug Sales Market Share by Country (2021-2032) Figure 25. North America Oral Anorexiant Drug Revenue Market Share by Country (2021-2032) Figure 26. United States Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Oral Anorexiant Drug Market Size by Country in 2025 Figure 30. Europe Oral Anorexiant Drug Sales Market Share by Country (2021-2032) Figure 31. Europe Oral Anorexiant Drug Revenue Market Share by Country (2021-2032) Figure 32. Germany Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Oral Anorexiant Drug Market Size by Country in 2025 Figure 43. Asia Pacific Oral Anorexiant Drug Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Oral Anorexiant Drug Revenue Market Share by Country (2021-2032) Figure 45. China Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Oral Anorexiant Drug Market Size by Country in 2025 Figure 54. South America Oral Anorexiant Drug Sales Market Share by Country (2021-2032) Figure 55. South America Oral Anorexiant Drug Revenue Market Share by Country (2021-2032) Figure 56. Brazil Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Oral Anorexiant Drug Market Size by Country in 2025 Figure 60. Middle East and Africa Oral Anorexiant Drug Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Oral Anorexiant Drug Revenue Market Share by Country (2021-2032) Figure 62. Egypt Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Oral Anorexiant Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Oral Anorexiant Drug Sales Market Share by Type (2021-2032) Figure 68. Global Oral Anorexiant Drug Revenue Market Share by Type (2021-2032) Figure 69. Global Oral Anorexiant Drug Price (US$/Unit) by Type (2021-2032) Figure 70. Global Oral Anorexiant Drug Sales Market Share by Application (2021-2032) Figure 71. Global Oral Anorexiant Drug Revenue Market Share by Application (2021-2032) Figure 72. Global Oral Anorexiant Drug Price (US$/Unit) by Application (2021-2032) Figure 73. Oral Anorexiant Drug Value Chain Figure 74. Oral Anorexiant Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Oral Anorexiant Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Catecholamines
  • Serotonin
Applications
  • Clinics
  • Hospitals
  • Online Pharmacies
  • Retail Sales
  • Other
Companies covered
  • Janssen Ortho
  • Teva Pharmaceuticals
  • Roche Pharmaceuticals
  • Recordati Rare Diseases
  • Patheon Pharmaceuticals
  • Novo Nordisk
  • MOVA Pharmaceuticals
  • Epic Pharma
  • Catalent Pharma Solutions
  • Arena Pharmaceuticals
  • Akrimax Pharmaceuticals
  • Abbott Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Anorexiant Drug Market Size (2021-2032)
  4. 2.2.2 Global Oral Anorexiant Drug Sales (2021-2032)
  5. 2.2.3 Global Oral Anorexiant Drug Market Average Price (2021-2032)
  6. 2.3 Oral Anorexiant Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Catecholamines
  9. 2.3.3 Serotonin
  10. 2.4 Oral Anorexiant Drug by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Clinics
  13. 2.4.3 Hospitals
  14. 2.4.4 Online Pharmacies
  15. 2.4.5 Retail Sales
  16. 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Anorexiant Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Anorexiant Drug Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Anorexiant Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Anorexiant Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Anorexiant Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Anorexiant Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Anorexiant Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Anorexiant Drug, Established Date
  9. 3.9 Global Oral Anorexiant Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Janssen Ortho
  2. 4.1.1 Janssen Ortho Company Information
  3. 4.1.2 Janssen Ortho Business Overview
  4. 4.1.3 Janssen Ortho Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Janssen Ortho Oral Anorexiant Drug Product Portfolio
  6. 4.1.5 Janssen Ortho Recent Developments
  7. 4.2 Teva Pharmaceuticals
  8. 4.2.1 Teva Pharmaceuticals Company Information
  9. 4.2.2 Teva Pharmaceuticals Business Overview
  10. 4.2.3 Teva Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Teva Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  12. 4.2.5 Teva Pharmaceuticals Recent Developments
  13. 4.3 Roche Pharmaceuticals
  14. 4.3.1 Roche Pharmaceuticals Company Information
  15. 4.3.2 Roche Pharmaceuticals Business Overview
  16. 4.3.3 Roche Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Roche Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  18. 4.3.5 Roche Pharmaceuticals Recent Developments
  19. 4.4 Recordati Rare Diseases
  20. 4.4.1 Recordati Rare Diseases Company Information
  21. 4.4.2 Recordati Rare Diseases Business Overview
  22. 4.4.3 Recordati Rare Diseases Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Recordati Rare Diseases Oral Anorexiant Drug Product Portfolio
  24. 4.4.5 Recordati Rare Diseases Recent Developments
  25. 4.5 Patheon Pharmaceuticals
  26. 4.5.1 Patheon Pharmaceuticals Company Information
  27. 4.5.2 Patheon Pharmaceuticals Business Overview
  28. 4.5.3 Patheon Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Patheon Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  30. 4.5.5 Patheon Pharmaceuticals Recent Developments
  31. 4.6 Novo Nordisk
  32. 4.6.1 Novo Nordisk Company Information
  33. 4.6.2 Novo Nordisk Business Overview
  34. 4.6.3 Novo Nordisk Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novo Nordisk Oral Anorexiant Drug Product Portfolio
  36. 4.6.5 Novo Nordisk Recent Developments
  37. 4.7 MOVA Pharmaceuticals
  38. 4.7.1 MOVA Pharmaceuticals Company Information
  39. 4.7.2 MOVA Pharmaceuticals Business Overview
  40. 4.7.3 MOVA Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 MOVA Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  42. 4.7.5 MOVA Pharmaceuticals Recent Developments
  43. 4.8 Epic Pharma
  44. 4.8.1 Epic Pharma Company Information
  45. 4.8.2 Epic Pharma Business Overview
  46. 4.8.3 Epic Pharma Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Epic Pharma Oral Anorexiant Drug Product Portfolio
  48. 4.8.5 Epic Pharma Recent Developments
  49. 4.9 Catalent Pharma Solutions
  50. 4.9.1 Catalent Pharma Solutions Company Information
  51. 4.9.2 Catalent Pharma Solutions Business Overview
  52. 4.9.3 Catalent Pharma Solutions Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Catalent Pharma Solutions Oral Anorexiant Drug Product Portfolio
  54. 4.9.5 Catalent Pharma Solutions Recent Developments
  55. 4.10 Arena Pharmaceuticals
  56. 4.10.1 Arena Pharmaceuticals Company Information
  57. 4.10.2 Arena Pharmaceuticals Business Overview
  58. 4.10.3 Arena Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Arena Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  60. 4.10.5 Arena Pharmaceuticals Recent Developments
  61. 4.11 Akrimax Pharmaceuticals
  62. 4.11.1 Akrimax Pharmaceuticals Company Information
  63. 4.11.2 Akrimax Pharmaceuticals Business Overview
  64. 4.11.3 Akrimax Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Akrimax Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  66. 4.11.5 Akrimax Pharmaceuticals Recent Developments
  67. 4.12 Abbott Pharmaceuticals
  68. 4.12.1 Abbott Pharmaceuticals Company Information
  69. 4.12.2 Abbott Pharmaceuticals Business Overview
  70. 4.12.3 Abbott Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Abbott Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  72. 4.12.5 Abbott Pharmaceuticals Recent Developments
5 Global Oral Anorexiant Drug Market Scenario by Region
  1. 5.1 Global Oral Anorexiant Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Anorexiant Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Anorexiant Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Anorexiant Drug Sales by Region: 2027-2032
  5. 5.3 Global Oral Anorexiant Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Anorexiant Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Anorexiant Drug Revenue by Region: 2027-2032
  8. 5.4 North America Oral Anorexiant Drug Market Facts & Figures by Country
  9. 5.4.1 North America Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Anorexiant Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Anorexiant Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Anorexiant Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Anorexiant Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Anorexiant Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Anorexiant Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Anorexiant Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Anorexiant Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Anorexiant Drug Market Facts & Figures by Country
  41. 5.7.1 South America Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Anorexiant Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Anorexiant Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral Anorexiant Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral Anorexiant Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral Anorexiant Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Anorexiant Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Anorexiant Drug Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oral Anorexiant Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Anorexiant Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Anorexiant Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Anorexiant Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Anorexiant Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Anorexiant Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Anorexiant Drug Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oral Anorexiant Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Anorexiant Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Anorexiant Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Anorexiant Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Anorexiant Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Anorexiant Drug Value Chain Analysis
  2. 8.1.1 Oral Anorexiant Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Anorexiant Drug Production Mode & Process
  5. 8.2 Oral Anorexiant Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Anorexiant Drug Distributors
  8. 8.2.3 Oral Anorexiant Drug Customers
9 Global Oral Anorexiant Drug Analyzing Market Dynamics
  1. 9.1 Oral Anorexiant Drug Industry Trends
  2. 9.2 Oral Anorexiant Drug Industry Drivers
  3. 9.3 Oral Anorexiant Drug Industry Opportunities and Challenges
  4. 9.4 Oral Anorexiant Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst